Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder
Phase 2
Completed
- Conditions
- Major Depressive Disorder
- Registration Number
- NCT00290914
- Lead Sponsor
- Pharmacology Research Institute
- Brief Summary
The purpose is to evaluate the safety and usefulness of the investigational drug, vilazodone in depression.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Male or female patients 18-65 years of age, inclusive.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method